DAN PUCKETT - 18 Apr 2022 Form 4 Insider Report for Shockwave Medical, Inc.

Signature
s/ Wade Estey, as attorney-in-fact for Dan Puckett
Issuer symbol
N/A
Transactions as of
18 Apr 2022
Net transactions value
-$908,852
Form type
4
Filing time
20 Apr 2022, 17:21:19 UTC
Previous filing
24 Feb 2022
Next filing
27 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Tax liability $208,137 -1,009 -2.4% $206.28 40,929 18 Apr 2022 Direct F1
transaction SWAV Common Stock Options Exercise $1,934 +480 +1.2% $4.03* 41,409 19 Apr 2022 Direct F2
transaction SWAV Common Stock Options Exercise $37,740 +2,220 +5.4% $17.00* 43,629 19 Apr 2022 Direct F2
transaction SWAV Common Stock Sale $368,961 -1,871 -4.3% $197.20 41,758 19 Apr 2022 Direct F2, F3
transaction SWAV Common Stock Sale $203,010 -1,000 -2.4% $203.01 40,758 19 Apr 2022 Direct F2, F4
transaction SWAV Common Stock Sale $81,768 -400 -0.98% $204.42 40,358 19 Apr 2022 Direct F2, F5
transaction SWAV Common Stock Sale $86,650 -420 -1% $206.31 39,938 19 Apr 2022 Direct F2, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWAV Stock Option Options Exercise $0 -480 -38% $0.000000 775 19 Apr 2022 Common Stock 480 $4.03 Direct F2, F7
transaction SWAV Stock Option Options Exercise $0 -2,220 -15% $0.000000 12,210 19 Apr 2022 Common Stock 2,220 $17.00 Direct F2, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All reported securities were sold at a price of $206.28.
F2 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022.
F3 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $197.06 to $198.05. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F4 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $202.55 to $203.47. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F5 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $204.05 to $204.88. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F6 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $205.78 to $206.70. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F7 1/48th of the shares subject to the option shall vest monthly from 07/19/2018.
F8 1/48th of the shares subject to the option shall vest monthly from 03/06/2019.